Displaying all 3 publications

Abstract:
Sort:
  1. Gulzar Y, Agarwal S, Soomro S, Kandpal M, Turaev S, Onn CW, et al.
    Front Big Data, 2025;8:1503883.
    PMID: 40046767 DOI: 10.3389/fdata.2025.1503883
    INTRODUCTION: Skin diseases significantly impact individuals' health and mental wellbeing. However, their classification remains challenging due to complex lesion characteristics, overlapping symptoms, and limited annotated datasets. Traditional convolutional neural networks (CNNs) often struggle with generalization, leading to suboptimal classification performance. To address these challenges, this study proposes a Hybrid Deep Transfer Learning Method (HDTLM) that integrates DenseNet121 and EfficientNetB0 for improved skin disease prediction.

    METHODS: The proposed hybrid model leverages DenseNet121's dense connectivity for capturing intricate patterns and EfficientNetB0's computational efficiency and scalability. A dataset comprising 19 skin conditions with 19,171 images was used for training and validation. The model was evaluated using multiple performance metrics, including accuracy, precision, recall, and F1-score. Additionally, a comparative analysis was conducted against state-of-the-art models such as DenseNet121, EfficientNetB0, VGG19, MobileNetV2, and AlexNet.

    RESULTS: The proposed HDTLM achieved a training accuracy of 98.18% and a validation accuracy of 97.57%. It consistently outperformed baseline models, achieving a precision of 0.95, recall of 0.96, F1-score of 0.95, and an overall accuracy of 98.18%. The results demonstrate the hybrid model's superior ability to generalize across diverse skin disease categories.

    DISCUSSION: The findings underscore the effectiveness of the HDTLM in enhancing skin disease classification, particularly in scenarios with significant domain shifts and limited labeled data. By integrating complementary strengths of DenseNet121 and EfficientNetB0, the proposed model provides a robust and scalable solution for automated dermatological diagnostics.

  2. Mesaik MA, Khan KM, Rahim F, Taha M, Haider SM, Perveen S, et al.
    Bioorg Chem, 2015 Jun;60:118-22.
    PMID: 26000491 DOI: 10.1016/j.bioorg.2015.05.003
    The synthetic indole Mannich bases 1-13 have been investigated for their ability to modulate immune responses measured in vitro. These activities were based on monitoring their affects on T-lymphocyte proliferation, reactive oxygen species (ROS), IL (interleukin)-2, IL-4, and nitric oxide production. Compound 5 was found to be the most potent immunomodulator in this context. Four of the synthesized compounds, 5, 11, 12, and 13, have significant potent inhibitory effects on T-cell proliferation, IL-4, and nitric oxide production. However, none of the thirteen indole compounds exerted any activity against ROS production.
  3. Khan KM, Mesaik MA, Abdalla OM, Rahim F, Soomro S, Halim SA, et al.
    Bioorg Chem, 2016 Feb;64:21-8.
    PMID: 26637945 DOI: 10.1016/j.bioorg.2015.11.004
    Benzothiazole and its natural or synthetic derivatives have been used as precursors for several pharmacological agents for neuroprotective, anti-bacterial, and anti-allergic activities. The objective of the present study was to evaluate effects of benzothiazole analogs (compounds 1-26) for their immunomodulatory activities. Eight compounds (2, 4, 5, 8-10, 12, and 18) showed potent inhibitory activity on PHA-activated peripheral blood mononuclear cells (PBMCs) with IC50 ranging from 3.7 to 11.9 μM compared to that of the standard drug, prednisolone <1.5 μM. Some compounds (2, 4, 8, and 18) were also found to have potent inhibitory activities on the production of IL-2 on PHA/PMA-stimulated PBMCs with IC50 values ranging between <4.0 and 12.8 μM. The binding interaction of these compounds was performed through silico molecular docking. Compounds 2, 8, 9, and 10 significantly suppressed oxidative burst ROS production in phagocytes with IC50 values between <4.0 and 15.2 μM. The lipopolysaccharide (LPS)-induced nitrites in murine macrophages cell line J774 were found to be inhibited by compounds 4, 8, 9, and 18 at a concentration of 25 μg/mL by 56%, 91%, 58%, and 78%, respectively. Furthermore, compounds 5, 8, 12, and 18 showed significant (P<0.05) suppressive activity on Th-2 cytokine, interleukin 4 (IL-4) with an IC50 range of <4.0 to 40.3 μM. Interestingly compound 4 has shown a selective inhibitory activity on IL-2 and T cell proliferation (naïve T cell proliferation stage) rather than on IL-4 cytokine, while compound 12 displayed an interference with T-cell proliferation and IL-4 generation. Moreover compound 8 and 18 exert non-selective inhibition on both IL-2 and IL-4 cytokines, indicating a better interference with stage leading to humoral immune response and hence possible application in autoimmune diseases.
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links